Olga V. Shelemekh

Olga V. Shelemekh

Auto-generated profile, based on publicly available information

Olga V. Shelemekh

Rostov State Medical University

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2023 in Research Results in Pharmacology
Verified
Journal Article
Closed access
PDF file
SLSvetlana Lebedeva
Svetlana Lebedeva
P(Pavel A. Galenko-Yaroshevsky (Jr.)
Pavel A. Galenko-Yaroshevsky (Jr.)
MSMikhail Samsonov
Mikhail Samsonov
AEArkadiy B. Erlich
Arkadiy B. Erlich
AZAnait Zelenskaya
Anait Zelenskaya
TDTatiana Demura
Tatiana Demura
Introduction: In the course of evolution, humans developed a number of complex multi-step wound healing mechanisms which limit the infectious agents access to the bloodstream, protect the organism from blood loss, and restore skin integrity. The process of skin wound healing includes the following stages: haemostasis, inflammation, proliferation, and remodeling. These processes are possible because of modulators, growth factors, cytokines, matrix metalloproteinases and cellular receptors, as well as some trace elements like zinc. Materials and Methods: The presented data was analyzed and compiled using all relevant articles describing the role of zinc in blood coagulation, proliferation, damaged tissues regeneration and angiogenesis. Results and Discussion: There are some on-going studies about zinc effects on blood coagulation, proliferation, damaged tissues regeneration and angiogenesis. However, molecular mechanisms of these processes are not yet fully understood and require further study. The analysis of scientific efforts to investigate the role of zinc in wound healing molecular mechanisms is especially relevant to the understanding of treatment of skin wound injuries. Conclusion: Wound healing is a complex multi-phase process consisting of several phases. Each stage involves metal ions, primarily zinc, which stimulates re-epithelialization, decreases inflammation and bacterial growth. The use of known zinc-based drugs is accompanied by side effects and low efficacy due to low skin absorption. These factors significantly limit use of such drugs and highlight the urgency of finding new, more effective and safe treatment. The emerging field of nanobiotechnology may provide an alternative platform to develop new therapeutic agents for the wound healing process. Graphical Abstract

30 January 2024 in Research Results in Pharmacology
Verified
Journal Article
Open access
PDF file
PGPavel A. Galenko-Yaroshevsky
Pavel A. Galenko-Yaroshevsky
OSOlga V. Shelemekh
Olga V. Shelemekh
VPViktor L. Popkov
Viktor L. Popkov
AZAndrey V. Zadorozhniy
Andrey V. Zadorozhniy
INIrina B. Nektarevskaya
Irina B. Nektarevskaya
NKNikolay E. Korovaykin
Nikolay E. Korovaykin
Introduction: Although nonsteroidal anti-inflammatory drugs (NSAIDs) have a clear therapeutic benefit, they can also have serious side effects. The most serious of these is the ulcerogenic effect, which can result in a decline in the quality of life or even death. This calls for the search for and creation of novel compounds with potent anti-inflammatory properties that do not have adverse effects on the digestive system. The aim of the study was to investigate the anti-inflammatory, analgesic, ulcerogenic and anti-ulcerogenic activities of N-isopropenylimidazole zinc complex derivative. Materials and Methods: Experiments in rats and mice were used to determine the median lethal dose LD50 for N-isopropenylimidazole zinc complex derivative (laboratory name Pilim-1). Experimental models of acute exudative inflammation and chronic proliferative inflammation were used. In the first case, the inflammation was induced by sub-plantar injection of carrageenan and a complete Freund’s adjuvant into the hind paw of rats. In the second case, the inflammation was induced by the implantation of a sterile cotton pellet (“cotton pellet–induced granuloma”) under the skin of rats. Acute and tonic pain, visceral, and somatic deep pain were simulated using the formalin test in rats and the acetic acid-induced writhing test in mice, respectively. The ulcerogenic and anti-ulcerogenic effects of Pilim-1 were studied in rat experiments. Pilim-1 and the reference drugs diclofenac, indomethacin and famotidine were administered intragastrically. Results and Discussion: Pilim-1 showed marked anti-inflammatory and analgesic effects, demonstrated less toxicity than diclofenac and indomethacin, while its activity is comparable to diclofenac and superior to indomethacin. Its therapeutic index is higher than that of indomethacin and diclofenac and, in contrast, it essentially has no ulcerogenic effect and exhibits stronger anti-ulcerogenic activity than famotidine. It appears that the anti-inflammatory, analgesic, and gastroprotective properties of Pilim-1 are largely due to its antioxidant and antihypoxic properties, its inhibitory effects on cyclooxygenase and 5-lipoxygenase, and the presence of imidazole and zinc in its structure, both of which have a wide range of biological activity. Conclusion: Pilim-1 can be recommended for further preclinical studies due to its relatively low (practically absent) ulcerative activity, strong anti-inflammatory, analgesic, and anti-ulcerative effects, greater therapeutic index, and less acute toxicity in comparison with diclofenac and indomethacin.

3 May 2024 in FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Verified
Journal Article
Open access
PDF file
PGPavel A. Galenko-Yaroshevsky
Pavel A. Galenko-Yaroshevsky
ITIvan Y Torshin
Ivan Y Torshin
AGA. N. Gromov
A. N. Gromov
OGOlga Gromova
Olga Gromova
RMRoman Murashko
Roman Murashko
OSO. V. Shelemekh
O. V. Shelemekh
Background. Nonsteroidal anti-inflammatory drugs (NSAIDs) are characterized by ulcerogenic effects and used for effective and safe pharmacotherapy of inflammation and pain. The zinc-containing drug acyzole is a promising anti-inflammatory drug that potentially does not have this drawback. Objective: to conduct chemoreactomic modeling of the pharmacological effects of acyzole and zinc derivatives of well-known NSAIDs (diclofenac, nimesulide, ketorolac).Material and methods. The analysis of the pharmacological capabilities of NSAIDs was based on a chemoinformatic approach, i.e. comparing the chemical structure of the studied molecules with the structures of millions of other molecules with established molecular pharmacological properties. The analysis procedure was based on the latest machine learning technologies developed in the theory of topological and metric analysis of feature descriptions.Results. It was shown that acyzole might have an anti-inflammatory effect due to its impact on the activity of cytokines and, partly, on the metabolism of prostaglandins and leuktrienes. The central effects of acyzole are comparable to those of zinc-NSAIDs. The analgesic effect of acyzole may be associated with kinin receptors inhibition, and weak antihistamine and antinociceptin effects. Acizol may also exhibit a gastroprotective effect. It was established that acyzole, to a lesser extent than the reference molecules, negatively affected the metabolism of vitamins and microelements.Conclusion. Chemoreactomic profiling of acyzole indicates prospects for its use as an anti-inflammatory drug.

11 November 2024 in Research Results in Pharmacology
Verified
Journal Article
Open access
PDF file
PGPavel A. Galenko-Yaroshevsky
Pavel A. Galenko-Yaroshevsky
IPIvan I. Pavlyuchenko
Ivan I. Pavlyuchenko
OSOlga V. Shelemekh
Olga V. Shelemekh
BTBoris A. Trofimov
Boris A. Trofimov
LPLidiya N. Parshina
Lidiya N. Parshina
SLSvetlana Lebedeva
Svetlana Lebedeva
Introduction: The combination treatment of patients with dentition problems including endodontic-periodontal lesions (EPL) is known to widely involve anti-inflammatory drugs, including non-steroidal anti-inflammatory agents, and antimicrobial drugs, in particular antibiotics and antiseptics, from which the former often lead to the development of gastro- and neuropathy, lesions of kidneys and liver, as well as the cardiovascular system, and the latter, in addition to serious side effects, lead to the development of steady resistance of pathogenic microorganisms and dysbacteriosis. This necessitates search for and development of new molecules with a wide range of therapeutic effects aimed to block the infectious and inflammatory process and to restore the functional ability of teeth in EPLs as much as possible (depending on a lesion severity). The aim of the study was to examine the anti-inflammatory, antioxidant, antimicrobial and mineralizing effects of an N-isopropenylimidazole zinc metal complex derivative in experimental endodontic-periodontal lesions in rats. Materials and Methods: EPL simulation in experiments on the anesthetized rats was conducted in the following way: first, the pulp cavity of lower incisors was opened and left exposed to infection; then periodontal inflammation was induced using a ligature. Thirty days later, EPL developed in the animals. An N-isopropenylimidazole zinc metal complex derivative (laboratory code Pilim-1, prepared in form of gel), reference drug Metrogyl Denta® (M-D, dental gel), as well as the combination Pilim-1 + M-D were applied daily for 14 days on the lower incisors and appropriate gums, and also placed in the gingival pockets and pulp cavities, with pulp partially removed beforehands. After euthanasia of the animals on the 15th day of the experiments, gingival homogenates were assayed for the activity of elastase, urease, catalase, the level of malondialdehyde, and the antioxidant-prooxidant index was calculated, while pulp homogenates were assayed for the activity of elastase, urease, alkaline and acidic phosphatases, and the mineralizing index was calculated. Results and Discussion: In the gum in EPL, Pilim-1 and, especially, the combination Pilim-1+M-D more significantly than M-D have a pronounced anti-inflammatory, antioxidant and antimicrobial (reduce a microbial content level) effects. In the pulp in EPL, Pilim-1 and, to a greater extent, the combination Pilim-1 + M-D in a more pronounced way than M-D have anti-inflammatory, antimicrobial (reduce a microbial content level) and mineralizing effects. In the therapeutic action mechanisms of Pilim-1 and, especially, the combination Pilim-1 + M-D in EPL conditions, their ability to have an antihypoxic effect and an inhibitory effect on cyclooxygenase and 5-lipoxygenase is likely to play a very important role, in addition to their identified effect on the examined metabolic processes. Besides, a certain role may be played by the presence of zinc and imidazole in the structure of Pilim-1, as they have a wide range of biological activity. Conclusion: The presented results of studying Pilim-1 and its combination with M-D indicate their high therapeutic efficiency, especially when using the latter in the experimental EPL in rats, which makes it possible to consider Pilim-1 and Pilim-1 + M-D as potential therapeutic agents to treat EPL.

22 July 2024 in Reviews on Clinical Pharmacology and Drug Therapy
Verified
Journal Article
Closed access
LSLiliya L. Shamal
Liliya L. Shamal
OSOlga V. Shelemekh
Olga V. Shelemekh
RMRoman Murashko
Roman Murashko
TGTereza R. Glechyan
Tereza R. Glechyan
PGPavel A. Galenko-Yaroshevsky
Pavel A. Galenko-Yaroshevsky
Issues of the effectiveness and safety of drugs remain relevant and controversial. The benefits and risks of drug therapy are two facets of one whole, called pharmacotherapy, which can have undesirable side and even negatively outweigh the benefits. The effectiveness and safety of drugs must be studied comprehensively because new effects of drugs may be discovered and new mechanisms for unregistered indications may be revealed. Moreover, a deep understanding of adverse drug reactions will allow for the accurate prescription of drugs and proper medical supervision of therapy. Nonsteroidal anti-inflammatory drugs are over-the-counter drugs perceived by patients as safe and do not require a doctor’s prescription, which can cause dangerous drug reactions, particularly when used uncontrollably. The review presents literature data from studies on the effectiveness of nonsteroidal anti-inflammatory drugs and current data on new therapeutic effects of individual drugs, risks of adverse reactions, their mechanisms, and treatment methods.

22 January 2026 in FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Verified
Journal Article
Open access
PDF file
PGPavel A. Galenko-Yaroshevsky
Pavel A. Galenko-Yaroshevsky
ASAlina Sergeeva
Alina Sergeeva
ITIvan Y Torshin
Ivan Y Torshin
AGA. N. Gromov
A. N. Gromov
OGOlga Gromova
Olga Gromova
NMN. N. Markarova
N. N. Markarova
Background. Zinc-containing compounds are a promising basis for the development of new non-steroidal anti-inflammatory drugs (NSAIDs), which can raise the effectiveness and safety of pharmaceutical management of inflammation and pain. Objective: To study the anti-inflammatory, ulcerogenic, etc., effects of zinc-imidazole complexes, such as allyl-2 (bis (N-allyl-2-methylimidazole) zinc diacetate), allim-2 (bis (N-allenyl-2-methylimidazole) zinc diacetate), and propargyl-2 (bis (N-propargyl-2-methylimidazole) zinc diacetate) in comparison with zinc complexes with known NSAIDs, such as diclofenac, nimesulide, and ketorolac. Material and methods. In silico modeling of candidate molecules allyl-2, allim-2, propargyl-2, zinc-diclofenac, zinc-nimesulide, and zinc-ketorolac was performed using a toolkit of chemoinformatic analysis methods developed by scientific school of Yu.I. Zhuravlev and K.V. Rudakov through topological analysis of chemographs and numerical forecasting of distinguishing features of complex systems. These methods include the theory of chemograph analysis, methods for predicting numerical target variables, the combinatorial theory of solvability/regularity, and topological methods for data analysis. The pharmacological capabilities of molecules within the framework of chemoreactome methodology were evaluated by comparing the chemical structure of the query molecule with the structures of molecules whose molecular-pharmacological properties have been established and available in the PubChem, HMDB, STRING, and PharmGKB databases. Results. The obtained chemoreactome evaluations revealed the capacity of zinc-imidazole complexes to inhibit of prostaglandin D2 binding to the prostaglandin D2 receptor on platelets (IC50 448–627 nM; zinc-NSAID: 588–997 nM) with comparable effects of zinc-imidazole complexes and zinc-NSAID on cyclooxygenase-2 (COX-2) inhibition in whole blood (IC50 295–428 nM). Zinc-imidazole complexes were characterized by a more pronounced inhibition of the proinflammatory signaling cascade of the NF-κB transcription factor (IC50 173–419 nM; zinc-NSAID 498–508 nM), alpha-1 adrenergic receptor (28 nM; zinc-NSAID: 235–411 nM), and angiotensin receptor-1 (IC50 16–22 nM; zinc-NSAID: 20–74 nM), indicating an antihypertensive effect. The antinociceptive activity of zinc-imidazole complexes (IC50 0.16 mg/kg) upon subcutaneous administration to mice in acetic acid-induced writhing was more pronounced than that of zinc-NSAIDs (0.9–1.0 mg/kg) with the exception of zinc-ketorolac (0.16 mg/kg). Compared to the zinc-NSAIDs, all zinc-imidazole complexes under study were characterized by similar and extremely low values ​​of antimicronutrient action scores (antivitamin score 0.38–0.61, antimicroelement score 0.37–0.88; compared to two- or three-fold higher scores for zinc-NSAIDs), which indicates the absence of adverse effects of zinc-imidazole complexes on micronutrient metabolism. Conclusion. The studied candidate molecules (zinc-imidazole complexes), in addition to COX inhibition, may exhibit additional pharmacological properties to a greater extent than the studied zinc complexes with known NSAIDs.